Nitric oxide synthase isoforms play distinct roles during acute peritonitis

Nephrology Dialysis Transplantation

Volumn 25, Issue 1, 2010, Pages 86-96

  Ni, Jie ^a   McLoughlin, Rachel M ^b   Brodovitch, Alexandre ^a   Moulin, Pierre ^a   Brouckaert, Peter ^c   Casadei, Barbara ^d   Feron, Olivier ^a   Topley, Nicholas ^b   Balligand, Jean Luc ^a   Devuyst, Olivier ^a  

^a UNIVERSITY OF LOUVAIN MEDICAL SCHOOL   (Belgium)

^b CARDIFF UNIVERSITY   (United Kingdom)

^c GHENT UNIVERSITY   (Belgium)

^d JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

Acute peritonitis; Knockout mice; LPS; NO synthases; Peritoneal dialysis

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; INDUCIBLE NITRIC OXIDE SYNTHASE; LIPOPOLYSACCHARIDE; NEURONAL NITRIC OXIDE SYNTHASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL; CELL PROLIFERATION; CONTROLLED STUDY; DIALYSATE; ENZYME INDUCTION; HEMATOCRIT; INFLAMMATION; KNOCKOUT MOUSE; LEUKOCYTE COUNT; MALE; MEAN ARTERIAL PRESSURE; METABOLITE; MORTALITY; MOUSE; NONHUMAN; PERITONEUM; PERITONITIS; PRIORITY JOURNAL; PROTEIN FUNCTION; SOLUTE; ULTRAFILTRATION; WILD TYPE;

ACUTE DISEASE; ANIMALS; DISEASE MODELS, ANIMAL; ISOENZYMES; LIPOPOLYSACCHARIDES; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; NITRIC OXIDE SYNTHASE TYPE I; NITRIC OXIDE SYNTHASE TYPE II; NITRIC OXIDE SYNTHASE TYPE III; PERITONEUM; PERITONITIS;

EID: 72949092054     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfp415     Document Type: Article

References (50)

1. Asano K, Chee CB, Gaston B et al. Constitutive and inducible nitric oxide synthase gene expression, regulation, and activityin human lung epithelial cells. Proc Natl Acad Sci USA 1994; 91: 10089-10093
2. Forstermann U, Boissel JP, Kleinert H. Expressional control of the 'constitutive' isoforms of nitric oxide synthase (NOS I and NOS III). FA S E B J 1998; 12: 773-790
3. Nakane M, Schmidt HH, Pollock JS et al. Cloned human brain nitric oxide synthase is highly expressed in skeletal muscle. FEBS Lett 1993; 316: 175-180
4. Wallerath T, Gath I, Aulitzky WE et al. Identification of the NO synthase isoforms expressed in human neutrophil granulocytes, megakaryocytes and platelets. Thromb Haemost 1997; 77: 163-167
5. 2+/calmodulin-dependent isoform in human B and T lymphocytes. Eur J Immunol 1996; 26: 511-516
6. Shaul PW, North AJ, Wu LC et al. Endothelial nitric oxide synthase is expressed in cultured human bronchiolar epithelium. J Clin Invest 1994; 94: 2231-2236
7. Xue C, Pollock J, Schmidt HH et al. Expression of nitric oxide syn-thase immunoreactivity by interstitial cells of the canine proximal colon. J Auton Nerv Syst 1994; 49: 1-14
8. Connelly L, Jacobs AT, Palacios-Callender M et al. Macrophage en-dothelial nitric-oxide synthase autoregulates cellular activation and pro-inflammatory protein expression. J Biol Chem 2003; 278: 6480-6487
9. Gokal R. Peritoneal dialysis in the 21st century: an analysis of current problems and future developments. J Am Soc Nephrol 2002; 13(Suppl 1): S104-S116
10. Krediet RT, Zuyderhoudt FMJ, Boeschoten EW et al. Alterations in the peritoneal transport of water and solutes during peritonitis in continuous ambulatory peritoneal dialysis patients. Eur J Clin Invest 1987; 17: 43-52
11. Douma CE, de Waart DR, Struijk DG et al. Are phospholipase A2 and nitric oxide involved in the alterations in peritoneal transport during CAPD peritonitis ? J Lab Clin Med 1998; 132: 329-340
12. Combet S, Van Landschoot M, Moulin P et al. Regulation of aquaporin-1 and nitric oxide synthase isoforms in a rat model of acute peritonitis. J Am Soc Nephrol 1999; 10: 2185-2196
13. Combet S, Balligand JL, Lameire N et al. A specific method for measurement of nitric oxide synthase enzymatic activity in peritoneal biopsies. Kidney Int 2000; 57: 332-338
14. Ferrier ML, Combet S, van Landschoot M et al. Inhibition of nitric oxide synthase reverses changes in peritoneal permeability in a rat model of acute peritonitis. Kidney Int 2001; 60: 2343-2350
15. Ni J, Moulin P, Gianello P et al. Mice that lack endothelial nitric oxide synthase are protected against functional and structural modifications induced by acute peritonitis. J Am Soc Nephrol 2003; 14: 3205-3216
16. Ni J, Cnops Y, McLoughlin RM et al. Inhibition of nitric oxide syn-thase reverses permeability changes in a mouse model of acute peritonitis. Perit Dial Int 2005; 25: S11-S14
17. Shesely EG, Maeda N, Kim HS et al. Elevated blood pressures in mice lacking endothelial nitric oxide synthase. Proc Natl Acad Sci USA 1996; 93: 13176-13181
18. Wei XQ, Charles IG, Smith A et al. Altered immune responses in mice lacking inducible nitric oxide synthase. Nature 1995; 375: 408-411
19. Huang PL, Dawson TM, Bredt DS et al. Targeted disruption of the neuronal nitric oxide synthase gene. Cell 1993; 75: 1273-1286
20. Ni J, Cnops Y, Debaix H et al. Functional and molecular characterization of a peritoneal dialysis model in the C57BL/6J mouse. Kidney Int 2005; 67: 2021-2031
21. Chantrain CF, DeClerck YA, Groshen S et al. Computerized quantification of tissue vascularization using high-resolution slide scanning of whole tumor sections. J Histochem Cytochem 2003; 51: 151-158
22. Ismail JA, Poppa V, Kemper LE et al. Immunohistologic labeling of murine endothelium. Cardiovasc Pathol 2003; 12: 82-90
23. Moncada S, Palmer M, Higgs E. Nitric oxide: physiology, pathophys-iology and pharmacology. Pharmacol Rev 1991; 43: 109-142
24. Devuyst O, Combet S, Cnops Y et al. Regulation of NO synthase isoforms in the peritoneum: implications for ultrafiltration failure in peritoneal dialysis. Nephrol Dial Transplant 2001; 16: 675-678
25. Goffin E, Combet S, Jamar F et al. Expression of aquaporin-1 in a long-term peritoneal dialysis patient with impaired transcellular water transport. Am J Kidney Dis 1999; 33: 383-388
26. Combet S, Miyata T, Moulin P et al. Vascular proliferation and enhanced expression of endothelial nitric oxide synthase in human peritoneum exposed to long-term peritoneal dialysis. J Am Soc Nephrol 2000; 11: 717-728
27. Combet S, Ferrier ML, Van Landschoot M et al. Chronic uremia induces permeability changes, increased nitric oxide synthase expression, and structural modificationsinthe peritoneum.J Am Soc Nephrol 2001; 12: 2146-2157
28. Miyata T, Devuyst O, Kurokawa K et al. Toward better dialysis compatibility: advances in the biochemistry and pathophysiology of the peritoneal membranes. Kidney Int 2002; 61: 375-386
29. Luster AD. Chemokines: chemotactic cytokines that mediate inflammation. N Engl J Med 1998; 338: 436-445
30. Gaboury J, Woodman RC, Granger DN et al. Nitric oxide prevents leukocyte adherence: role of superoxide. Am J Physiol 1993; 265: H862-H867
31. Kubes P, Suzuki M, Granger DN. Nitric oxide: an endogenous modulator of leukocyte adhesion. Proc Natl Acad Sci USA 1991; 88: 4651-4655
32. Kubes P, Granger DN. Nitric oxide modulates microvascular permeability. Am J Physiol 1992; 262: H611-H615
33. Topley N, Liberek T, Davenport A et al. Activation of inflammation and leukocyte recruitment into the peritoneal cavity. Kidney Int Suppl 1996; 56: S17-S21
34. Cirino G, Fiorucci S, Sessa WC. Endothelial nitric oxide synthase: the Cinderella of inflammation? Trends Pharmacol Sci 2003; 2: 91-95
35. Thiemermann C. Nitric oxide and septic shock. Gen Pharmacol 1997; 2: 159-166 (Pubitemid 27312364)
36. Nathan CF, Hibbs JB Jr. Role of nitric oxide synthesis in macrophage antimicrobial activity. Curr Opin Immunol 1991; 1: 65-70
37. Szabo C, Thiemermann C. Regulation of the expression of the in-ducible isoform of nitric oxide synthase. Adv Pharmacol 1995; 34: 113-153
38. Hickey MJ, Sharkey KA, Sihota EG et al. Inducible nitric oxide synthase-deficient mice have enhanced leukocyte-endothelium interactions in endotoxemia. FASEB J 1997; 11: 955-964
39. McCafferty DM, Mudgett JS, Swain MG et al. Inducible nitric oxide synthase plays a critical role in resolving intestinal inflammation. Gastroenterology 1997; 112: 1022-1027
40. Yan G, You B, Chen SP et al. Tumor necrosis factor-alpha downregu-lates endothelial nitric oxide synthase mRNA stability via translation elongation factor 1-alpha 1. Circ Res 2008; 103: 591-597
41. Michel T, Feron O. Perspective series: nitric oxide synthases. J Clin Invest 1997; 100: 2146-2152
42. Wallerath T, Gath I, Aulitzky WE et al. Identification of the NO synthase isoforms expressed in human neutrophil granulocytes, megakaryocytes and platelets. Thromb Haemost 1997; 77: 163-167
43. Bachetti T, Comini L, Curello S et al. Co-expression and modulation of neuronal and endothelial nitric oxide synthase in human endothelial cells. J Mol Cell Cardiol 2004; 37: 939-945
44. Schwarz PM, Kleinert H, Forstermann U. Potential functional significance of brain-type and muscle-type nitric oxide synthase I expressed in adventitia and media of rat aorta. Arterioscler Thromb Vasc Biol 1999; 19: 2584-2590
45. Comtois AS, Barreiro E, Huang PL et al. Lipopolysaccharide-induced diaphragmatic contractile dysfunction and sarcolemmal injury in mice lacking the neuronal nitric oxide synthase. Am J Respir Crit Care Med 2001; 163: 977-982
46. Ortiz PA, Garvin JL. Cardiovascular and renal control in NOS-deficient mouse models. Am J Physiol Regul Integr Comp Physiol 2003; 284: R628-R638
47. Lefer DJ, Jones SP, Girod WG et al. Leukocyte-endothelial cell interactions in nitric oxide synthase-deficient mice. Am J Physiol 1999; 276: H1943-H1950
48. Tao F, Tao YX, Zhao C et al. Differential roles of neuronal and en-dothelial nitric oxide synthases during carrageenan-induced inflammatory hyperalgesia. Neuroscience 2004; 128: 421-430
49. Lirk P, Hoffmann G, Rieder J. Inducible nitric oxide synthase-time for reappraisal. Curr Drug Targets Inflamm Allergy 2002; 1: 89-108
50. Paige JS, Jaffrey SR. Pharmacologic manipulation of nitric oxide signalling: targeting NOS dimerization and protein-protein interactions. Curr Top Med Chem 2007; 7: 97-114